Streptococcal toxic shock syndrome: Ten years, experience at a tertiary hospital;Síndrome del shock tóxico estreptocócico: Experiencia de los últimos 10 años en un hospital terciario

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 23, Issue 9, 2005, Pages 540-544

  Vallalta Morales, Manuel ^a,d   Salavert Lletí, Miguel ^a   Artero Morac, Arturo ^b   Mahiques Santos, Laura ^c   Solaz Moreno, Elena ^a   Pérez Bellés, Carmen ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^d NONE   (Spain)

Author keywords

Necrotizing fasciitis; Streptococcal toxic shock syndrome; Streptococcus pyogenes

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; CLINDAMYCIN; IMIPENEM; LEVOFLOXACIN; METRONIDAZOLE; PENICILLIN DERIVATIVE; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ADULT; AGED; AMPUTATION; ARTICLE; BLOOD CULTURE; CLINICAL ARTICLE; DEBRIDEMENT; FEMALE; HOSPITAL INFECTION; HUMAN; INFECTION SENSITIVITY; MALE; MORTALITY; NECROTIZING FASCIITIS; RETROSPECTIVE STUDY; SKIN INFECTION; SOFT TISSUE INFECTION; STREPTOCOCCUS; STREPTOCOCCUS PYOGENES; TOXIC SHOCK SYNDROME;

EID: 28144442675     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: 10.1157/13080264     Document Type: Article

References (10)

1. Stevens DL. Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment. Emerg Infect Dis. 1995;1:69-78.
2. The Working Group on Severe Streptococcal Infections. Denning the group A Streptococcal toxic shock syndrome. Rationale and consensus definition. JAMA. 1993;269:390-1.
3. Stevens DL, Tanner MH, Winship J, Swarts R, Ries KM, Schlievert PM, et al. Severe group A Streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med. 1989;321:1-7.
4. Bernaldo de Quirós JC. Estreptococo del grupo A: las nuevas caras de un viejo conocido. Enferm Infecc Microbiol Clin. 1995;13:273-7.
5. Davies HD, McGeer A, Schwartz B, Green K, Cann D, Simor AE, et al. Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. N Engl J Med. 1996;335:547-54.
6. Barnham MR, Weightman NC, Anderson AW, Tanna A. Streptococcal toxic shock syndrome: a description of 14 cases from North Yorkshire, UK. Clin Microbiol Infect. 2002;8:174-81.
7. Bernaldo de Quirós JC, Moreno S, Cercenado E, Díaz D, Berenguer J, Miralles P, et al. Group A Streptococcal bacteremia. A 10-year prospective study. Medicine (Baltimore). 1997;76:238-48.
8. Erikson BKG, Andersson J, Holm SE, Norgren M. Epidemiological and clinical aspects of invasive group A streptococcal infections and the streptococcal shock toxic syndrome. Clin Infect Dis. 1998;27:1428-36.
9. Bosch T, Riera M, Galmés M, Ramírez A, Albertí S. Infecciones invasoras por estreptococos del grupo A: características clinicas y análisis microbiológicos de 31 casos. Enferm Infecc Microbiol Clin. 2001;19:371-5.
10. Norrby-Teglund A, Ragnar Norrby S, Low DE. The treatment of severe group A streptococcal infections. Curr Infect Dis Rep. 2003;5:28-37.